Benadrin

Quick links to important sections

Benadrin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benadrin

Property Description
Active ingredient Diphenhydramine (as the hydrochloride salt)
Form Capsule, Tablet, Oral solution, Topical cream, Injectable solution
Pharmacological class First-Generation H1 Receptor Antagonist
General purpose Relieving allergy symptoms, promoting sedation
Origin Synthetic Ethanolamine-derivative

What Type of Medicine is Benadrin (Diphenhydramine)?

Benadrin is a trade-name pharmaceutical preparation containing the active ingredient Diphenhydramine, recognized clinically as an effective allergy blocker. This medicine is firmly classified as a First-Generation Antihistamine, chemically identified as a Histamine H1 Receptor Antagonist. This pharmacological classification is based on its mechanism of receptor blockade.

The core substance, Diphenhydramine, is a synthetic compound derived from the Ethanolamine-derivative chemical class. Its structure facilitates significant CNS penetration, a key feature differentiating it from newer, second-generation antagonists, and is directly responsible for the sedative effects that characterize its use.


Composition and Available Forms of Benadrin

The composition of the trade name Benadrin centers on the active substance, Diphenhydramine hydrochloride, which functions as a single-ingredient product. Multiple forms of Diphenhydramine are available, including the injectable solution often reserved for clinical settings, and forms like the capsule, tablet, and oral solution for patient use.

Its availability in various pharmaceutical preparations is a defining feature, allowing for both systemic delivery via oral consumption and targeted relief via topical cream or ointment for dermal applications. This versatility ensures the delivery of the active agent across different primary routes of administration.


What is the General Purpose of This First-Generation H1 Blocker?

The general purpose of Benadrin is to provide relief from symptoms associated with allergic reactions by initiating the competitive antagonism of histamine receptors. This foundational action defines its role as a primary allergy blocker.

In addition to this function, the medicine is clinically recognized for its significant inherent properties as an anticholinergic agent, which is responsible for a distinct drying effect on mucous membranes. Furthermore, the capacity for high CNS penetration is why it is often chosen for its intended use in promoting sedation and temporary calmness, broadening its general utility among H1 antagonists.

Regulatory References

  1. Diphenhydramine - LiverTox - NIH

What side effects are possible with Benadrin?

Possible side effects and safety information

The safety profile for medicines containing Diphenhydramine is based exclusively on classifications and observations documented in government-approved prescribing information, such as the FDA Labeling and the European Summary of Product Characteristics (SmPC). The most common adverse reactions are linked to the medicine's central nervous system (CNS) activity.


Frequency and System Classification

Adverse reactions are formally categorized by frequency and the body system affected:

  • Very Common / Common: The highest frequency effects include drowsiness (somnolence), sedation, fatigue, and dizziness. Common anticholinergic effects include dry mouth, constipation, and urinary retention. These are often most pronounced at the beginning of treatment.
  • System-Organ Classes: Effects are documented across Nervous System Disorders (e.g., disturbed coordination), Gastrointestinal Disorders (e.g., nausea, vomiting), and Eye Disorders (e.g., blurred vision).

Serious Reactions and Safety Constraints

Regulatory documents also list rare but clinically significant effects and mandatory safety constraints:

  • Serious Adverse Reactions: Rare events include severe blood dyscrasias (e.g., agranulocytosis), seizures (convulsions), and the potential for serious cardiovascular toxicity (e.g., QTc prolongation) associated with excessive doses.
  • Safety Constraints: Due to the risk of impaired cognitive and motor skills, the medicine may affect the ability to drive or operate machinery. Concurrent use with alcohol or other CNS depressants is documented to result in an additive depressant effect.

Population-Specific Considerations

Safety characteristics are noted to differ in specific populations:

  • Older Adults: This population is documented to be more susceptible to side effects, including increased risk for dizziness, sedation, and pronounced anticholinergic effects (e.g., confusion, urinary retention).
  • Pediatric Patients: May experience paradoxical excitation (restlessness, agitation) rather than the expected sedation.

Overdose and Emergency Response

A documented overdose of Diphenhydramine (Benadrin) is characterized by a specific spectrum of physiological manifestations that require urgent intervention as mandated by regulatory authorities. The central nervous system (CNS) can exhibit two main extremes: either severe depression, leading to profound sedation and unresponsiveness, or paradoxical excitation, particularly observed in children, resulting in agitation, hallucinations, and tremors.

The presentation often includes signs of anticholinergic toxicity, such as rapid heartbeat (tachycardia), fixed and dilated pupils (mydriasis), flushing, and urinary retention. Official labeling warns that severe overdosage can lead to life-threatening outcomes, including seizures, serious cardiac arrhythmias (like QTc prolongation), cardiovascular collapse, and death.

Because of these documented severe risks, regulatory guidance requires seeking immediate medical attention and contacting emergency services for any suspected overdose, especially if unresponsiveness, a seizure, breathing difficulty, or collapse occurs. Treatment is described as symptomatic and supportive; no specific antidote is known. Monitoring procedures, such as continuous ECG observation, are required to manage potential cardiac effects.

Therapeutic Uses of Benadrin

What Benadrin Treats: Main Uses and Benefits

The therapeutic utility of this medication is commonly applied across domains where additional symptomatic support is needed, primarily focusing on managing symptoms related to heightened physiological activity associated with irritative states, temporary sleep difficulty, and certain motor or balance issues. Its applications span several distinct therapeutic areas.

This medicine is generally used to help address symptom clusters that may appear suddenly, relevant in conditions characterized by periods of heightened symptoms. It is commonly used to provide symptomatic relief from allergic conditions, including hay fever (allergic rhinitis), runny nose, sneezing, itchy eyes, and localized discomfort from minor skin irritations or widespread itching (pruritus). Furthermore, it is applied for the management of motion sickness and associated nausea/dizziness, and is relevant for easing symptoms associated with occasional difficulty falling asleep (insomnia) in adults.

“It is commonly used when short-term symptomatic assistance is needed across domains involving heightened physiological activity and temporary functional strain.”

The medication helps maintain a sense of stability when symptoms are more noticeable, supporting the patient during difficult episodes by easing distress across these varied clinical scenarios.


Quick Fact: Supports easing Allergic Symptom Burden and Symptom-Related Sleep Disruption

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Benadrin?

Regulatory documentation strictly defines the populations eligible for Benadrin (Diphenhydramine) based on absolute prohibitions and necessary cautions.


Absolute Contraindications (Must Not Use)

Population / Condition
Neonates and Premature Infants
Nursing Mothers / Women who are breast-feeding
Known Hypersensitivity to diphenhydramine
Stenosing peptic ulcer or Pyloroduodenal obstruction
Concomitant use with other preparations containing diphenhydramine

Age-Related Eligibility and Restrictions

Age Group Eligibility Status
Under 2 Years Do Not Use oral products (FDA/Health Canada)
12 Years and Older Generally eligible for standard OTC use
Older Adults (Approx. ge 60 years) Not Recommended or Use with Caution due to high risk of dizziness and confusion

Conditional Use (Requires Caution)

Diphenhydramine should be used with caution in patients with a history of narrow-angle glaucoma, prostatic hypertrophy (or other conditions causing difficulty urinating), bronchial asthma, hypertension, cardiovascular disease, and conditions leading to moderate to severe hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several categories of interacting substances with Diphenhydramine (Benadrin), primarily due to shared physiological effects or metabolic pathways.

Interaction Classifications

Category Official Interaction Statement
Contraindicated Combinations Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated due to the potential to intensify anticholinergic effects. Concomitant use with any other product containing Diphenhydramine is also strictly prohibited.
Additive Effects Combining with Central Nervous System (CNS) Depressants (including alcohol, hypnotics, sedatives, and tranquilizers) results in additive pharmacodynamic effects, significantly increasing the risk of sedation and CNS depression.
Pharmacokinetic Effects Diphenhydramine is an inhibitor of the CYP2D6 isoenzyme. Co-administration with medicines that are primarily metabolized by this enzyme (e.g., Metoprolol, Venlafaxine) may lead to an altered clearance or increased systemic exposure of those co-administered drugs.
Population Note The regulatory label notes that elderly patients (age 60 or older) are more susceptible to adverse pharmacodynamic effects, such as increased dizziness, sedation, and hypotension, when taking antihistamines.

These official statements define the drug's interaction profile, requiring strict avoidance of specific combinations (MAOIs, self-similar products) and careful monitoring when co-administered with other CNS-acting or CYP2D6-metabolized agents.

Mechanism of Action

How Benadrin Works

Primary Mechanism: Central and Peripheral H1 Receptor Blockade

The core mechanism of action involves Diphenhydramine binding to and stabilizing the inactive state of the Histamine H1 Receptor as an inverse agonist. This action effectively prevents endogenous histamine from activating these receptors in both the peripheral tissues and the brain. The resulting physiological consequence of this blockade includes alteration of histamine-driven responses, with resulting decreased capillary permeability and reduced sensory nerve excitability.


Mechanism of CNS Depression

A defining feature of this molecule is its high lipophilicity, which allows for rapid and extensive crossing of the blood-brain barrier. Once centrally active, the drug's H1 receptor blockade interferes with the histaminergic neurotransmission pathways critical for maintaining wakefulness. This targeted pathway adjustment results in a physiological consequence of central nervous system depression, characterized by an increase in neuronal slowing.


Secondary Anticholinergic and Local Effects

Beyond its primary target, Diphenhydramine acts as an antagonist at Muscarinic Acetylcholine Receptors, engaging the parasympathetic autonomic pathway. This secondary mechanism limits signaling to exocrine glands, resulting in reduced glandular secretions. Separately, the molecule exhibits an intrinsic ability to interfere with voltage-gated Sodium ( Na^+) Channels on nerve membranes, causing reduced local nerve excitability.

Dosage and Administration Information

The official use of Diphenhydramine, the active ingredient in Benadrin, is defined by specific administration routes, standardized dosage ranges, and regulated scheduling. The medicine is primarily taken via the oral route in formulations such as capsules, tablets, or oral solution. In clinical settings, the injectable solution is approved for parenteral administration via either a deep intramuscular (IM) or slow intravenous (IV) injection, though the injectable form is only indicated when oral intake is impractical.

For general use, the standard adult oral dose ranges from 25 mg to 50 mg and is administered every four to six hours. When used for temporary sleep assistance, the official dose is 50 mg taken as a single dose at bedtime. Regulatory labeling establishes a strict maximum daily dose for oral intake, not to exceed 300 mg in a 24-hour period.

When administering the injectable solution, the intravenous infusion rate must be controlled and generally not exceed 25 mg per minute. Specific administration constraints include a universal rule against using this product concurrently with any other medication containing diphenhydramine, including topical preparations. Dosage guidelines for pediatric patients are based on body weight or surface area, and over-the-counter formulations are specifically restricted from use in children under six years of age.

Recent Clinical Evidence

Research evidence / Overview of studies for Benadrin

Evidence for Symptom Relief in Allergic Conditions

Research examining allergic conditions includes short-term, controlled Randomized Controlled Trials (RCTs) and systematic reviews. The research explored outcomes related to physical discomfort, using patient-reported symptom severity scores. Findings describe patterns observed in these short-term trials, particularly regarding the onset and duration of the response that was monitored. Comparative evidence, examining Benadrin alongside newer types of allergy medicine, was also monitored. Evidence remains limited regarding consistent long-term outcomes related to repeated use over extended periods.

Research Supporting Temporary Sleep and Sedation

The research focusing on temporary difficulty sleeping (occasional insomnia) includes various randomized controlled trials (RCTs). Studies monitored subjective sleep parameters, such as the time taken to fall asleep (sleep onset latency), and next-day consequences, specifically assessing outcomes reflecting daily functioning and psychomotor performance. The certainty remains low regarding the consistent pattern of measured response on sleep parameters with continuous use, as the rapid development of tolerance to the sedating pattern is examined as a primary limitation.

Study Data for Motion Sickness Prevention

Research for motion sickness primarily consists of controlled trials that were evaluated in the context of managing the potential for motion sickness symptoms (prophylaxis). The research examined outcomes describing episodic or acute changes, such as the incidence and severity of nausea and vomiting in observed populations. Studies report how symptoms evolved when the medicine was administered shortly before exposure to the motion. Data for certain groups, particularly younger children, remain insufficient, and the research provides limited insight into the approach or outcomes for managing the condition once symptoms are already established.

Evidence Gaps and Areas of Uncertainty

A key limitation is that results apply primarily to short-term scenarios, and long-term effects are not fully established. The certainty remains low regarding the sustained pattern of response for repeated use due to the potential for tolerance development, which studies have monitored. Overall, research provides insight into short-term changes and episodic patterns, but does not determine whether an individual will respond similarly over the long term.

Key Studies & References

  1. Diphenhydramine in insomniac family practice patients: a double-blind study - PubMed (RCT supporting use as an OTC sleep aid)

Frequently Asked Questions (FAQ)

Common questions about Benadrin (FAQ)

Q: What is Benadrin primarily used for besides allergies?

A: Official product information states that the active ingredient in Benadrin is also used to treat occasional insomnia, which is temporary difficulty falling asleep or staying asleep. Additionally, it is indicated for the prevention and treatment of motion sickness and for easing certain symptoms of the common cold.

Q: What's the difference between Benadrin and other common cold medicines?

A: Benadrin is an antihistamine. It works by blocking histamine and can help dry up nasal secretions. Many other common cold medicines are multi-ingredient products that may combine an antihistamine like Benadrin with other types of medicine, such as pain relievers, fever reducers, or decongestants.

Q: Why do some people say they have a paradoxical reaction to Benadrin (getting energized instead of sleepy)?

A: Paradoxical excitation, which means experiencing restlessness or agitation instead of the expected sedation, is a documented adverse reaction. Regulatory documents indicate that this reaction is primarily associated with pediatric patients, though unexpected reactions can occur in any population.

Q: Is Benadrin safe to take if I'm pregnant or breastfeeding (general information)?

A: Official information notes that while animal studies have not demonstrated risk, there are no adequate, controlled studies in pregnant women to confirm safety. Crucially, the medicine must not be used by nursing mothers, as it is known to pass into breast milk and may cause adverse reactions in infants.

Q: Can Benadrin be used for motion sickness prevention?

A: Yes, official labeling confirms that Benadrin is indicated for the prevention and treatment of symptoms associated with motion sickness.

Q: Is Benadrin safe for children to use, and is there a specific formulation for kids?

A: Regulatory documents state that oral products must not be used in children under two years old, with further restrictions applying to those under six years of age. Liquid and chewable forms of diphenhydramine are available, which allows for administration in children who cannot swallow pills.

Q: What's the difference between Benadrin tablets, capsules, and liquid forms?

A: All forms contain the same active ingredient. Official documentation notes that the product is available as tablets, capsules, and an oral liquid solution. The liquid and chewable forms are often available for children or for individuals who have difficulty swallowing pills.

Q: Are there generic versions of Benadrin, and are they equally effective?

A: Yes, the active ingredient, diphenhydramine, is widely available in generic formulations. Generic versions are manufactured to contain the same active ingredient and are required by regulatory bodies to demonstrate the same quality, strength, and effectiveness as the original brand-name product.

Q: Is the sedation from Benadrin stronger in certain age groups?

A: Official regulatory information indicates that certain populations are more susceptible to side effects. Specifically, older adults are generally noted to be more susceptible to experiencing side effects, including increased sedation.

Q: Can Benadrin be used as a pre-medication before certain procedures?

A: Official information indicates that the active ingredient, primarily in its injectable form, is reserved for and administered in clinical settings for pre-medication purposes before certain treatments.

Q: What are the signs that Benadrin is not working for my symptoms?

A: Official guidance suggests that if allergy or cold symptoms do not start to improve, or if they get worse after taking the medicine, discontinuation of the medicine is generally suggested. Specifically, if a cough lasts longer than one week, returns, or is accompanied by a fever, a healthcare provider should be consulted.

Q: What are common user-reported experiences when first starting Benadrin?

A: According to the official safety profile, the most common effects are often most pronounced at the beginning of treatment. These typically include drowsiness, sedation, fatigue, dizziness, and anticholinergic effects like dry mouth.

Q: Can Benadrin be applied topically, and how does that work?

A: Yes, diphenhydramine is available as a topical cream, lotion, gel, or spray for external use. It works topically by blocking histamine in the skin to temporarily relieve itching from insect bites, minor burns, or minor skin irritations.

Q: How quickly does Benadrin start working after you take it?

A: The clinical profile indicates that the onset of action occurs rapidly after administration. Effects are generally experienced shortly after, which aligns with the typical recommended dosing frequency of every four to six hours.

Q: How long do the effects of Benadrin typically last?

A: The effects of a single dose of Benadrin are generally noted to last for four to six hours. This duration is generally consistent with the typical interval between doses indicated in the product information.

Q: Can Benadrin help with sleep problems, and if so, how?

A: Official indications show Benadrin is used to help with occasional difficulty sleeping. The medicine's high ability to cross into the brain is responsible for its sedating effect, as it interferes with brain pathways critical for maintaining wakefulness.

Q: Can Benadrin be used for motion sickness relief?

A: Official labeling confirms that Benadrin is indicated for the prevention and treatment of motion sickness. However, official research focuses on the management of symptoms when the medicine is administered before exposure to motion, providing limited insight into managing the condition once symptoms are already established.

Q: What types of medications should I check for potential interactions with Benadrin?

A: Official regulatory documents emphasize a potential for increased sedation when combined with any medications that cause Central Nervous System (CNS) depression. This includes alcohol, sleeping pills, sedatives, and tranquilizers. Additionally, it is important to check product labels to avoid taking any other medication that contains the same active ingredient.

Q: Does Benadrin interact with common pain relievers like ibuprofen or acetaminophen?

A: Official warnings focus on major interactions, particularly with CNS depressants. While the medicine can inhibit a specific enzyme ( CYP2D6), official warnings about enzyme inhibition focus on a specific class of medicines and do not typically call out simple pain relievers like ibuprofen or acetaminophen as major interaction concerns.

Q: Is it normal to feel a little groggy the morning after taking Benadrin?

A: Drowsiness and fatigue are listed as common side effects of the medicine. Studies related to its use for sleep also monitored next-day consequences, indicating that feeling 'groggy' or impaired the following morning is a recognized possibility.

Q: Can Benadrin be taken with food, or does it matter?

A: Regulatory administration instructions do not typically specify that the medicine must be taken with respect to food.

Q: Is there any research about Benadrin's long-term safety?

A: Research and official summaries indicate that the evidence for Benadrin's safety and effectiveness is mainly based on short-term use. Regulatory documents state that long-term effects are not fully established, and there is low certainty about sustained effectiveness due to the potential for the rapid development of tolerance.

Q: What is the maximum number of days it's generally recommended to take Benadrin consecutively?

A: Official labeling sets a strict maximum daily dose but does not specify a maximum number of days for continuous use. Given that research evidence is based on short-term use, continuous use is not supported by long-term data.

Q: Are there specific food restrictions while taking Benadrin?

A: Official warnings focus on interactions with alcohol and certain other medicines. There are generally no specific restrictions noted in official documentation regarding common food or non-alcoholic beverage consumption while taking Benadrin.

Q: Why do people sometimes misuse Benadrin?

A: Regulatory documents link the potential for serious adverse reactions, such as cardiovascular toxicity, to the ingestion of excessive doses, which underscores the risks associated with misuse of the product.

Q: Why might a doctor suggest Benadrin for non-allergic conditions?

A: Beyond its anti-allergy function, Benadrin has inherent properties as an anticholinergic agent that causes a drying effect on mucous membranes. Its high ability to cause sedation is why it is often chosen for non-allergic conditions where a calming or sedative effect is desired.

How should Benadrin be stored and disposed of?

The storage and disposal of Benadryl (diphenhydramine) are defined by strict regulatory requirements to ensure product quality and public safety.

Storage Conditions

The medicine must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and, for light-sensitive forms, protected from light. Liquid and injectable formulations must be protected from freezing. Always store the product in the original container and verify that the safety seal is intact.

Child Safety

All forms must be kept out of the sight and reach of children as a mandatory label instruction.

Disposal Instructions

Unused or expired medicine should be disposed of in accordance with local requirements. Regulatory guidelines prohibit disposal via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Benadrin found in:

A-Z Index: